PATENT CLAIM ANALYSIS

Application Number: 16007853
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["435", "006120"]

Abstract:
Compositions, systems and methods for the diagnosing the risk of acute myocardial infarction are provided. The methods described herein relate to the use of biomarkers, such as gene expression profiles, and analytical tools for providing information to a health care provider or the patient, that is relevant to the cardiovascular health of the patient.

Claim (Index 203):
The method any of  claims 191 - 200 , wherein the one or more genes is selected from among HBEGF, NR4A2, NR4A3, EFEMP1, NFKBIA, NLRP3, and combinations thereof.

Metadata:
- Claim Count in Document: 75.0
- Percentile: 94.0
- Lexical Diversity: 1.42857
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14714063', '15313493', '14426430', '13913077', '12745220']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5606143406255855
- 35 USC 102 Novelty (BERT): 0.7282198883668869
- Combined Prediction Score: 0.5773748953997156
- Mean Citation Score: 435.4076480000001
- Max Citation Score: 1192.7365
- Similarity Product: 802.262403974861

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test